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Subjects and Methods: 
With the use of MRI relaxometry (before and after CA) of mouse brains with 
implanted tumors, we calculate quantitative maps (Q‑maps) with an in house 
developed program. These Q‑maps are used for the synthesization of different 
parametric weighted images offline and compared to standard acquired images 
of the same weightings.
Results: With the use of the SPARE technique, contrast between tissue in‑
creases and the noise, within the image, is reduced. It is further shown that 
unattainable parameters at the MR scanner can be achieving though synthesis, 
allowing for higher enhancement and tissue differentiation. Furthermore, 
SPARE using T2 Q‑maps alone, allows visualization of CA enhance tumors 
and high image contrast between the bounding tissue.
Discussion/Conclusion: Parameter‑weighted images reconstructed retro‑
spectively with SPARE offers higher tissue contrast and reduced noise for 
different combination of TR and TE. Using the SPARE technique thus offers 
a solution for overcoming the lost contrast due to the convergence of T1 at 
high magnetic field strengths.
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Purpose/Introduction: Glioblastoma is the most frequent primary brain tu‑
mour but despite the advances achieved in the last decades in treating human 
malignancies, its prognosis has not experienced a great change (1). In this line, 
magnetic resonance imaging (MRI) is the most used and versatile tool used 
nowadays (2), and PET/CT has become of clinical importance as it can also 
offer additional metabolic information with a high sensitivity (3,4). This study 
aimed to characterize a rat model of glioma C6, by using multiparametric MRI 
and comparing results with the data provided by 18F‑FDG‑PET/CT.
Subjects and Methods: Male Wistar rats (N=17) were submitted to a surgical 
injection of 105 C6 cells in their right caudate‑putamen. Sham animals (N=5) 
were used as a control group. All the individuals were studied with MRI, 
when tumour’s volume was 10‑100 mm3, using a 7T system and the following 
protocol: T2, T2* and T1 weighted images to yield relaxation time maps, dif‑
fusion tension imaging (DTI) to obtain mean diffusivity (MD) and fractional 
anisotropy (FA) maps, and magnetization transfer (MT) to determine the MT 
ratio maps. Colour based maps were computed pixel‑by‑pixel, by fitting the 
signal to the appropriate equation, using a home‑made software developed 
in Matlab. Data were analysed by selecting ROI’s in the tumour, contralateral 
hemisphere and healthy tissue. Six animals (5 tumour‑bearing and 1 control) 
were also submitted to an 18F‑FDG‑PET/CT study, analysing ROI’s in the 
tumour, contralateral hemisphere and liver.
Results: Results are shown in figures 1‑6. Tumour ROI´s compared with Sham 
animals, showed significantly different values of MTR, T1, T2 and T2*. The 
comparison between the tumour region and its contralateral hemisphere was 
also relevant on the MT, MD, T1, T2 and T2* measurements. By comparing 
the tumour and healthy tissue, there were significant differences on MT, FA, 
T1 and T2. PET/CT images showed tumour regions with significantly higher 
SUV values when compared to their contralateral, although a clear correlation 
between the SUV values and the MRI parameters could not be found.
Discussion/Conclusion: There are significant differences in MRI parameters 
related to inflammation, oedema and hypoxia between tumour areas and both 
the contralateral hemisphere and healthy. 18F‑FDG‑PET/CT images provided 
a new type of information, which can be used additionally to the MRI data. 
This characterization can help in the proper selection and follow‑up of patients 
who will benefit from tailored therapies, mainly those targeting angiogenesis 
and inflammation.
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Purpose/Introduction: Alterations in inflammation and microvasculature 
underlying the most complicated brain pathologies, like cancer. A deeper 
characterization of the inflammatory and tumoral microenvironment would 
improve the diagnosis and prognosis of neoplastic process and the validation 
of new‑targeted therapies. In this line, MRI is established as a powerful tool 
for obtaining structural, functional and molecular information1,2.
Subjects and Methods: Experiments were carried out using sham adult male 
Wistar (n=5) and glioma bearing animals in two stages of the tumor growth 
(early, n=10, tumors≤50µl; late, n=10 tumors≥75µl).
MRI experiments were performed on a 7.0‑T horizontal system equipped with 
a 1H selective birdcage resonator. The imaging protocol was: Magnetization 
transfer, MT (TR/TE= 2500/9.85 ms, 50 pulses, 5.5 µT, 1500 Hz); diffusion 
tensor imaging, DTI (TR/TE= 3000/40 ms, Δ/δ= 20/4 ms, 7 directions, b 
values 300 and 1400 s/mm2); and dynamic contrast enhanced, DCE (TR/TE= 
100/6 ms, 50 repetitions)
Images were computed on a pixel‑by‑pixel basis using My Map Analizer 
(in‑house software developed in Matlab) and the obtained parametric maps 
were analyzed in three brain regions: tumor, contralateral hemisphere and 
apparently healthy tissue.
Results: Figures 1‑4 depict the main results. Values measured in all cases 
showed significant differences between the regions and groups of animals 
assesed. Changes in MT and MD values are linked to the tumor progression, 
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the concomitant inflammation and edema. MT (fig.1) decreased in tumor 
compared with non‑tumoral regions, and increases in late stages indicating 
alteration in the macromolecular‑bound proton pool associated with the pa‑
thology and its progression. MD (fig.2) reflected the extension of the cellular 
swelling due to the inflammatory process, taking place in the brain just the 
tumor growing. Decreases in FA (fig.3) were correlated with the structural 
integrity loss in the brain because of the tumor´s presence. A higher ΔSI of 
larger tumors in DCE studies was in accordance with the expected increase 
in the disruption of the microvasculature in the late stages.
Discussion/Conclusion: Multiparametric MRI studies in this glioma model 
have allowed establishing clear and significant differences between regions in 
the brain, associated with the development not only of the tumor but also of the 
associated inflammation. MTR and MD measurements have clearly indicated 
that apparently healthy regions in the brain are actually affected in the late 
stage of the tumor development. DCE analysis indicate either an increased 
in the vascular permeability in large tumors compared with smaller ones.
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Purpose/Introduction: The increased glycolytic rate and glucose avidity of 
malignant cells (Warburg effect) in comparison to normal tissue is the basis of 
the ability of FDG‑PET imaging to accurately differentiate cancer from benign 
tissue regardless of morphology. The two glucose analogs 2‑deoxy‑D‑glucose 
(2‑DG) and 2‑fluoro‑2‑deoxy‑D‑glucose (FDG) are preferentially taken up 
by cancer cells, undergo phosphorylation and accumulate in the cells. Both 
2‑DG and FDG have 4 hydroxyl residues, which are potential candidates 
for Chemical Exchange Saturation Transfer CEST NMR/MRI. The method 
enables to detect low concentrations of metabolites that contain residues with 
exchangeable protons such hydroxyl1.
In the present work we take advantage of the enhanced accumulation of 2‑DG 
and FDG in tumors to obtain large CEST values and would like to suggest either 
2‑DG‑CEST or FDG‑CEST as a potential replacement of PET/CT or PET/MRI 
in the clinic for the detection of tumors and metastases, distinguishing between 
malignant and benign tumors and monitoring tumor response to therapy.
Subjects and Methods: CEST‑MRI experiments were performed on implanted 
xenograph mammary tumors (DA3) of mice injected with 2‑DG or FDG, 
scanned at 7T MRI. A series of gradient‑echo images were collected from a 
single 1 mm axial slice after presaturation pulse, applied at several frequency 
offsets from the water, to produce the desired CEST effect2.
Results: The tumor exhibited a CEST effect of about 20% for mice injected with 
2gr/kg of 2‑DG and about 30% for mice injected with 1gr/kg of FDG. These 
high values are the combined results originating from the injected glucose 
analogs, their phosphorylated products and from other metabolic products.
The diagnostic benefit and uniqueness of this technique, is that the method 
is sensitive enough to detect regional differences in tumor uptake. We have 
shown that 2‑DG CEST MRI enables to distinguish between the viable parts 
of tumor from the necrotic region of the tumor, unlike the conventional 
anatomical images.
Discussion/Conclusion: This novel imaging modality will also shed a new light 
on tumor basal metabolism, expression of tumor markers and the metabolic 
alteration induced by constitutive activation of oncogenes in tumor develop‑
ment. We expect that the developed novel imaging modality will enable early 
detection of tumors, tumor response to therapy, and tumors metabolism 
noninvasively by using MRI, without the need for radio‑labeled isotopes.
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Purpose/Introduction: The usefulness of the Technetium‑99m labeled Ses‑
tamibi SPECT modality in addition to the MRI modality has been suggested 
in therapy management for patients with high grade glioma [1]. The SPECT/
MRI registration that is required for further data analysis is a complex pre‑
processing step due to the physiological distribution of the MIBI tracer. This 
work aims at proposing an efficient registration of SPECT/MRI data, which 
is optimized for each dataset.
Subjects and Methods: The database includes 62 SPECT/MRI datasets in 
patients with high grade glioma. The registration strategy consists in testing 
different methods and selecting the best one for each dataset thanks to a quan‑
titative uptake criterion (UC), based on the physiological behavior of Sestamibi 
within particular anatomical structures [2]. The criterion relies on the high 
uptake of the tracer in the oculomotor muscles and pituitary gland and the 
low uptake in the eyeballs. Global strategy proceeds in 3 steps, embedded in 
the Brainvisa/Anatomist package: 1) a systematic application of 16 registration 
methods (Mn) derived from algorithms of Brainvisa and SPM software; 2) for 
each dataset, ranking of the 16 methods according to decreasing values of UC 
and selection of the best registration method, M* ; 3) visual assessment of M* 
as good, intermediate, or bad registration.
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